Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Tadalafil 5mg for Treatment of Female Overactive Bladder Syndrome :6 Months Follow up

NCT04500860 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT04500860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04500860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Tadalafil 5mg for Treatment of Female Overactive Bladder Syndrome :6 Months Follow up
Lead sponsor
Kasr El Aini Hospital
Phase
Phase 1
Overall status
Completed
Start date
December 1, 2020
Completion date
July 1, 2022
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female patients with overactive bladder syndrome or female patients with urgency or urgency urinary incontinence